Neal Potischman
Lawyers
Filters
Davis Polk Secures Denial of TRO on behalf of Tezos Stiftung in Securities Class Action
On December 20, 2017, Davis Polk obtained the denial of an application for a temporary restraining order that sought to freeze the assets of its client Tezos Stiftung (or the Tezos…
Memorial Production Partners Reaches Plan Support Agreement with Noteholders
Davis Polk is advising an ad hoc group of holders of the senior unsecured notes of Memorial Production Partners LP in connection with the pending chapter 11 restructuring of Memorial…
Davis Polk Advises Second-Lien Noteholders in Connection with Confirmation of Midstates Petroleum Company, Inc. $2 Billion Restructuring Plan
Davis Polk is advising an ad hoc group of holders of the second-lien notes of Midstates Petroleum Company, Inc. in connection with Midstates Petroleum’s chapter 11 bankruptcy case in…
Cisco obtains declinations from DOJ and SEC in FCPA investigations
Davis Polk advised Cisco Systems, Inc. (“Cisco”) on investigations conducted by the U.S. Securities and Exchange Commission (“SEC”) and the U.S. Department of Justice (“DOJ”) into potential…
Dismissal of price-fixing claims against SD-card joint venture
Davis Polk won a dismissal of antitrust claims brought by an alleged class of indirect purchasers of SD Card Flash Memory devices in a case of first impression before the U.S. District…
First Wind Holdings resolution of commercial disputes
We successfully resolved several disputes on behalf of the wind energy company
Victory and Favorable Settlement for Dialog Semiconductors
Davis Polk successfully represented Dialog Semiconductors in litigation related to the earnout provisions in its 2013 acquisition of iWatt. In April 2014, Fortis Advisors—acting on behalf…
Davis Polk Advises Broadcom on Its Acquisition by Avago Technologies
Davis Polk is advising the special committee of Broadcom Corporation’s board of directors in connection with the company’s approximately $37 billion acquisition by Avago Technologies…
Davis Polk Advises Micrel on Its Sale to Microchip
Davis Polk is advising Micrel, Incorporated in connection with its sale to Microchip Technology Incorporated for a total equity value of approximately $839 million. The transaction,…
Davis Polk Obtains Dismissal for Orexigen Directors in a Stock Compensation Derivative Litigation
Davis Polk represents several current and former directors of Orexigen Therapeutics (the “Company”) in connection with derivative litigation relating to the award of equity compensation. On…